A Comparison Between Corifollitropin Alfa and Recombinant FSH for Follicular Recruitment in Women With Polycystic Ovaries Who Undergo IVM Treatment
Phase of Trial: Phase III
Latest Information Update: 30 Oct 2018
At a glance
- Drugs Corifollitropin alfa (Primary) ; Follitropin beta
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- Acronyms Elonva_IVM
- 19 Oct 2018 Planned End Date changed from 31 Dec 2018 to 1 Jul 2019.
- 19 Oct 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
- 08 May 2018 Status changed from not yet recruiting to recruiting.